Italy Longevity Diagnostics Market Size & Outlook, 2026-2033
The longevity diagnostics market in Italy is expected to reach a projected revenue of US$ 100.1 million by 2033. A compound annual growth rate of 6.2% is expected of Italy longevity diagnostics market from 2026 to 2033.
Revenue, 2025 (US$M)
$62.5
Estimate, 2026 (US$M)
$65.7
Forecast, 2033 (US$M)
$100.1
CAGR, 2026 - 2033
6.2%
Global Market
Related Markets
Italy longevity diagnostics market highlights
- The Italy longevity diagnostics market generated a revenue of USD 62.5 million in 2025 and is expected to reach USD 100.1 million by 2033.
- The Italy market is expected to grow at a CAGR of 6.2% from 2026 to 2033.
- In terms of segment, epigenetic age testing was the largest revenue generating test type in 2025.
- Multi-Omics Profiling is the most lucrative test type segment registering the fastest growth during the forecast period.
Longevity diagnostics market data book summary
| Market revenue in 2025 | USD 62.5 million |
| Market revenue in 2033 | USD 100.1 million |
| Growth rate | 6.2% (CAGR from 2026 to 2033) |
| Largest segment | Epigenetic age testing |
| Fastest growing segment | Multi-Omics Profiling |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Epigenetic Age Testing, Telomere Length Analysis, Multi-Omics Profiling, Proteomics-Based Aging Biomarkers, Metabolomics Testing, Microbiome Aging Diagnostics, Hormone & Metabolic Profiling |
Other key industry trends
- In terms of revenue, Italy accounted for 2.2% of the global longevity diagnostics market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Europe, Germany longevity diagnostics market is projected to lead the regional market in terms of revenue in 2033.
- UK is the fastest growing regional market in Europe and is projected to reach USD 310.1 million by 2033.
No credit card required*
Publish Date: May 12, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Longevity Diagnostics Market Scope
Longevity Diagnostics Market segmentation & scope
Longevity Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| 23andMe Holding Co Class A | View profile | 816 | 349 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 | www.23andme.com |
| Knovos | View profile | 251-500 | Fairfax, Virginia, United States, North America | www.knovos.com/ |
| Nebula Genomics | View profile | 11-50 | San Francisco, California, United States, North America | www.nebula.org |
| Abbott | View profile | - | - | - |
| Elysium | View profile | 11-50 | New York, New York, United States, North America | www.elysiumhealth.com |
| SiPhox Health | View profile | 11-50 | Burlington, Massachusetts, United States, North America | siphoxhealth.com |
| TruDiagnostic | View profile | 51-100 | Lexington, Kentucky, United States, North America | trudiagnostic.com |
| GlycanAge | View profile | 11-50 | Newcastle Upon Tyne, Newcastle upon Tyne, United Kingdom, Europe | glycanage.com |
| Tally Health | View profile | 11-50 | New York, New York, United States, North America | www.tallyhealth.com |
Italy Longevity Diagnostics Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Longevity Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Epigenetic Age Testing was the largest segment with a revenue share of 27.2% in 2025.
Horizon Databook has segmented the Italy longevity diagnostics market based on epigenetic age testing, telomere length analysis, multi-omics profiling, proteomics-based aging biomarkers, metabolomics testing, microbiome aging diagnostics, hormone & metabolic profiling covering the revenue growth of each sub-segment from 2021 to 2033.
- Italy Longevity Diagnostics Market Test Type Outlook (Revenue, USD Million , 2021-2033)
- Epigenetic Age Testing
- Telomere Length Analysis
- Multi-Omics Profiling
- Proteomics-Based Aging Biomarkers
- Metabolomics Testing
- Microbiome Aging Diagnostics
- Hormone & Metabolic Profiling
- Italy Longevity Diagnostics Market Technology Outlook (Revenue, USD Million , 2021-2033)
- Next-Generation Sequencing (NGS)
- Mass Spectrometry
- AI-Powered Analytics
- Microarray Technology
- Wearable-Integrated Monitoring
- Italy Longevity Diagnostics Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Direct-to-Consumer (DTC)
- Longevity Clinics
- Hospitals & Clinical Laboratories
- Others
Reasons to subscribe to Longevity Diagnostics Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Longevity Diagnostics Market Outlook databook
- Our clientele includes a mix of Longevity Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy Longevity Diagnostics Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Italy Longevity Diagnostics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Italy Longevity Diagnostics Market, 2021-2033 (US$M)
Italy longevity diagnostics market statistics, by test type, 2021-2033 (US$M)
